RSV non-fusion inhibitors (Vaxart)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameRSV non-fusion inhibitors (Vaxart)
Drug Alias NameRSV non-fusion inhibitors (Aviragen Therapeutics)RSV non-fusion inhibitors (Biota Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus uptake inhibitors
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxart Biosciences IncVaxart Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A